How CAR T-Cell Therapy Transforms Mantle Cell Lymphoma Treatment
CAR T-cell therapy stands as a revolutionary advancement in the treatment of mantle cell lymphoma, a challenging subtype of Non-Hodgkin Lymphoma known for its resistance to conventional therapies. This innovative approach utilizes genetically engineered T-cells to target cancerous cells, offering promising results with FDA-approved options like brexucabtagene autoleucel and lisocabtagene maraleucel. Explore the transformative mechanisms […]
3 minute read